Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Celestial
Shenzhen, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Shenzhen Celestial is a biotechnology company based in Shenzhen, China, specializing in the development of advanced cell therapies for oncology. The company focuses on chimeric antigen receptor T-cell (CAR-T) technologies, targeting hematological malignancies such as leukemia and lymphoma. Their research and development efforts are centered on optimizing CAR-T constructs to improve efficacy and safety profiles in clinical settings. Shenzhen Celestial operates a pipeline that includes programs targeting CD19 and BCMA, aiming to provide next-generation treatment options for patients with refractory or relapsed cancers. The company is actively engaged in early-stage clinical trials to validate its therapeutic candidates.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyCAR-T cell therapyBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on Shenzhen Celestial.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Celestial.